For over a decade, Greg Wurtz has helped pharmaceutical manufacturers utilize data and quantitative analysis to make better business decisions, evolve existing products, and design new ones. Since 2011, Greg has made advanced commercial analytics useful and tied to business goals, drawing on his strengths in business storytelling and strategic thinking. His experience gives him perspective across the universal truths of pharmaceutical manufacturers and at the intersection of business intelligence design, technical implementation, and strategy development.

Greg’s clients at PharmaTrade Analytics view him as a trusted business partner who acts as a business sociologist of sorts in uncovering problems and underserved needs, and then synthesizing learnings into actionable solutions. During his line of questioning, he often hears, “This guy understands me!” He’s valued for objectively clarifying what matters and speaking the language of the business (rather than tech and specs). Because Greg was an advanced user of data assets when he formerly managed marketing programs, he understands how to tie data to everyday business applications and customer solutions. Greg’s clients have included Pharmaceuticals, Astra Zeneca, Bayer, Chiesi Pharmaceuticals, Johnson & Johnson, Jazz Pharmaceuticals, Kowa Pharmaceuticals, Lupin, Mayne Pharmaceuticals, Mylan, Nutricia, Purdue Pharmaceuticals, and Upsher Smith Laboratories.

Greg joined ValueCentric in 2011 and became an expert in leveraging ValueTrak and developing customer best practices and custom solutions. When IQVIA acquired ValueCentric, Greg became part of the consulting/data strategy group, where he applied creative thinking to the uses of aggregated customer data. He then was an Innovation Manager at IQVIA, developing new solutions and business cases for Master Data Management and Gross-to-Net platforms. Greg earned his MBA from Boston University.